Literature DB >> 28646510

Compound muscle action potential duration in critical illness neuromyopathy.

Christopher L Kramer1, Andrea J Boon1, C Michel Harper1, Brent P Goodman2.   

Abstract

INTRODUCTION: We sought to determine the specificity of compound muscle action potential (CMAP) durations and amplitudes in a large critical illness neuromyopathy (CINM) cohort relative to controls with other neuromuscular conditions.
METHODS: Fifty-eight patients with CINM who had been seen over a 17-year period were retrospectively studied. Electrodiagnostic findings of the CINM cohort were compared with patients with axonal peripheral neuropathy and myopathy due to other causes.
RESULTS: Mean CMAP durations were prolonged, and mean CMAP amplitudes were severely reduced both proximally and distally in all nerves studied in the CINM cohort relative to the control groups. The specificity of prolonged CMAP durations for CINM approached 100% if they were encountered in more than 1 nerve. DISCUSSION: Prolonged, low-amplitude CMAPs occur more frequently and with greater severity in CINM patients than in neuromuscular controls with myopathy and axonal neuropathy and are highly specific for the diagnosis of CINM. Muscle Nerve 57: 395-400, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ICU acquired weakness; compound muscle action potential amplitude; compound muscle action potential duration; critical illness myopathy; critical illness neuromyopathy; critical illness neuropathy; nerve conduction study

Mesh:

Year:  2017        PMID: 28646510     DOI: 10.1002/mus.25732

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Multimodal assessment of intensive care unit-acquired weakness in severe stroke patients.

Authors:  Berin Inan; Can Ebru Bekircan-Kurt; Zeynep Ergul-Ulger; Merve Yilmaz; Zeliha Gunnur Dikmen; Ethem Murat Arsava; Mehmet Akif Topcuoglu; Omur Caglar; Merve Basol; Ergun Karaagaoglu; Sevim Erdem-Ozdamar; Ersin Tan; Cagri Mesut Temucin
Journal:  Acta Neurol Belg       Date:  2022-07-06       Impact factor: 2.471

2.  Reply to "Comprehensive work-up is warranted for patients with severe COVID-19 and muscle weakness including respiratory muscles".

Authors:  Lidia Cabañes-Martínez
Journal:  Clin Neurophysiol       Date:  2020-12-25       Impact factor: 3.708

3.  Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?

Authors:  Viviana Versace; Luca Sebastianelli; Davide Ferrazzoli; Leopold Saltuari; Markus Kofler; Wolfgang Löscher; Antonino Uncini
Journal:  Front Neurol       Date:  2021-01-29       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.